1. Which of the following is not a potential consequence of insulin deficiency and resulting hyperglycemia?

2. According to the Diabetes Control and Complications Trial (DCCT), intensive glucose control reduces the risk for all of the following in people with type 1 diabetes (T1DM), except:

3. True or false? A1C provides an accurate picture of glycemic variability in those with T1DM.

4. Which agent works to reduce hyperglycemia in those with T1DM by increasing endogenous GLP-1?

5. A person with T1DM who requires reduced A1C, reduced fasting plasma glucose, reduced total daily insulin dose, and reduced waist circumference would benefit from which of the following:

« Return to Activity